Evidence map›Paper›PMID 22621771›Full record

ArticleInternational wound journal2013

Wound healing by topical application of antioxidant iron chelators: kojic acid and deferiprone.

Mehrdad Mohammadpour, Mohaddeseh Behjati, Amir Sadeghi, Afshin Fassihi

Open access · greenAbstract readComparative Study
In one paragraph

Article in International wound journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Deferiprone-Gallium-Protoporphyrin Chitogel DecreasesMaterials (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Molecules (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. The Unexplored Wound Healing Activity ofMolecules (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Antibiotics Affect ROS Production and Fibroblast Migration in anFrontiers in cellular and infection microbiology · 2020
    Article
  13. Article
  14. Article
  15. African Herbal Remedies with Antioxidant Activity: A Potential Resource Base for Wound Treatment.Evidence-based complementary and alternative medicine : eCAM · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mehrdad MohammadpourDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohaddeseh Behjati
Amir Sadeghi
Afshin Fassihi
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kojic acid and deferiprone are iron chelators used for skin lightening and iron-overload treatment, respectively. As iron chelation and free radical scavenging are principal factors for wound healing, it was hypothesised that the local application of these compounds might accelerate wound healing in rats. Ointments of 3%, 6% and 9% of deferiprone and kojic acid were prepared and topical treatment was performed on in vivo wound models for 12 days twice in day for test and control groups. Topical treatment with 3%, 6% and 9% showed significant improvement in wound healing after 4 days (P < 0·001). Topical application of 3% and 6% deferiprone enhanced wound healing after 8 days (P < 0·026 and P < 0·001, respectively). Accelerated wound healing was seen using 3% and 6% deferiprone after 12 days (P = 0·003 and P < 0·001, respectively). DPPH scavenging assay was also performed to compare the antioxidant potencies of kojic acid and deferiprone. Deferiprone had more free radical scavenging power than kojic acid. Generally, deferiprone topical treatment, accelerated wound healing more than kojic acid because of its higher antioxidant and iron chelation abilities.

Indexed as

Administration, TopicalAnimalsAntioxidantsDeferiproneDisease Models, AnimalDrug Therapy, CombinationFemaleIron Chelating AgentsMycotoxinsPyridonesPyronesRatsRats, WistarSkin UlcerTreatment OutcomeWound HealingAntioxidantsDeferiproneIron Chelating Agentskojic acidMycotoxinsPyridonesPyrones

Identifiers

PMID22621771
PMCPMC7950824
OpenAlexW2001076434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.